Joint Formulary & PAD

Ajmaline - Diagnosis of Brugada syndrome

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Red
Formulations :
  • Injection
Associated Icons :
Restrictions / Comments :

Documentation

  • No records returned.

PAD Profile

ChemicalSubstance :
Ajmaline
Indication :
Diagnosis of Brugada syndrome
Group Name :
Keywords :
Gilurytmal
Brand Names Include :
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
0

Other Indications

Below are listed other indications that Ajmaline is used to treat.

  • No records returned.

Other Drugs

Below are listed other drugs that are used to treat Diagnosis of Brugada syndrome.

  • No records returned.

Committee Recommendations (1)

The Surrey Heartlands Area Prescribing Committee agreed the traffic light status of this drug and indication as part of the Joint Formulary review.